J&J Files 8-K/A Amendment with Debt Details
Ticker: JNJ · Form: 8-K/A · Filed: Jan 22, 2025 · CIK: 200406
Sentiment: neutral
Topics: debt-filing, amendment, financial-exhibits
Related Tickers: JNJ
TL;DR
J&J dropped an 8-K/A amendment detailing its various notes due between 2028 and 2044.
AI Summary
Johnson & Johnson filed an 8-K/A amendment on January 22, 2025, to report financial statements and exhibits. This filing specifically includes details about various notes due in November 2028, November 2032, 2035, November 2036, and November 2044, with coupon rates ranging from 1.150% to 3.550%.
Why It Matters
This filing provides updated information on Johnson & Johnson's outstanding debt instruments, offering transparency to investors regarding the company's long-term financing structure.
Risk Assessment
Risk Level: low — This is a routine amendment to a previous filing, primarily providing updated financial exhibits and debt instrument details, with no new material events disclosed.
Key Numbers
- 1.150% — Notes Due November 2028 (Interest rate on specific debt)
- 3.550% — Notes Due November 2044 (Interest rate on specific debt)
Key Players & Entities
- JOHNSON & JOHNSON (company) — Registrant
- January 22, 2025 (date) — Filing date
- 1.150% Notes Due November 2028 (dollar_amount) — Debt instrument
- 3.550% Notes Due November 2044 (dollar_amount) — Debt instrument
FAQ
What is the purpose of this 8-K/A filing by Johnson & Johnson?
The purpose of this 8-K/A filing is to amend a previous report and provide updated financial statements and exhibits.
What specific debt instruments are detailed in this filing?
The filing details notes due in November 2028, November 2032, 2035, November 2036, and November 2044.
What is the earliest maturity date for the notes mentioned in the filing?
The earliest maturity date for the notes mentioned is November 2028.
What is the highest interest rate mentioned for the debt instruments?
The highest interest rate mentioned is 3.550% for notes due November 2044.
When was this 8-K/A filing submitted to the SEC?
This 8-K/A filing was submitted to the SEC on January 22, 2025.
Filing Stats: 516 words · 2 min read · ~2 pages · Grade level 9.6 · Accepted 2025-01-22 16:55:07
Key Financial Figures
- $1.00 — ich registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 1.150% Not
Filing Documents
- jnj-20250122.htm (8-K/A) — 33KB
- a2024q4exhibit9912.htm (EX-99.1) — 146KB
- image_0.jpg (GRAPHIC) — 3KB
- image_1.jpg (GRAPHIC) — 0KB
- 0000200406-25-000007.txt ( ) — 382KB
- jnj-20250122.xsd (EX-101.SCH) — 3KB
- jnj-20250122_def.xml (EX-101.DEF) — 8KB
- jnj-20250122_lab.xml (EX-101.LAB) — 31KB
- jnj-20250122_pre.xml (EX-101.PRE) — 19KB
- jnj-20250122_htm.xml (XML) — 7KB
01 Financial statements and exhibits
Item 9.01 Financial statements and exhibits (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Press Release dated January 22, 2025 for the period ended December 29, 2024 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 22, 2025 JOHNSON & JOHNSON (Registrant) By: /s/ Robert J. Decker, Jr. Robert J. Decker, Jr. Controller (Principal Accounting Officer)